Try our Advanced Search for more refined results

Deals Rumor Mill: Teva, Colony Capital, Riverstone Holdings

By Benjamin Horney (May 6, 2016, 5:52 PM EDT) -- Teva Pharmaceutical Industries Ltd. has nearly clinched up to $2 billion worth of asset sale agreements to help its $40.5 billion proposed purchase of Allergan PLC's generics business, according to a Friday report from Reuters. According to the report, Teva is in the process of finalizing a series of deals that will see the company agree to divest about 50 drugs that are already on the market and 25 that are in development. Teva agreed to buy the generics unit in July, and in March the European Commission greenlighted the deal, contingent on certain concessions....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!